Across TCGA pan-cancer cohorts, LINC00272 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC00272’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00272 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00272 is over-expressed in tumor, although a few such as THCA and READ show the opposite, repressed pattern.

KIRC, LIHC, and THCA are the cancer types where LINC00272 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00272 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.051	<.001	6	view →
LIHC	Male	All	+0.310	.007	4	view →
THCA	All	All	−0.090	<.001	4	view →
READ	All	II,III,IV	−0.155	.025	3	view →
UCEC	All	All	−0.130	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC00272 RNA expression & survival · all LINC00272 data types